))
Lung Cancer Edition: Top Headlines for Week of May 8, 2023
Manage episode 407442272 series 3560281
Konten disediakan oleh Healio. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Healio atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.
In this edition, tumor mutational burden linked to immunotherapy response; toripalimab regimen extends EFS in stage III NSCLC; phase 3 study designed for increasing trial diversity, and more.
Read the full coverage here:
Tumor mutational burden may be linked to immunotherapy response in advanced cancers
Perioperative toripalimab regimen extends EFS in resectable stage III NSCLC
Phase 3 study of lung cancer regimen designed to be a model for increasing trial diversity
Smoking cessation before lung cancer diagnosis significantly reduces excess mortality risk
Pembrolizumab active in diffuse malignant peritoneal mesothelioma
References:
Aggarwal C, et al. JAMA Netw Open. 2023;doi:10.1001/jamanetworkopen.2023.11181.
Lu S, et al. Abstract 425126. Presented at: ASCO Plenary Series: April 2023 Session; April 20, 2023.
Marmarelis ME, et al. JAMA Netw Open. 2023;doi:10.1001/jamanetworkopen.2023.2526.
Pragmatica-Lung Study, a streamlined model for future cancer clinical trials, begins enrolling patients (NCI press release). Published April 12, 2023. Accessed April 12, 2023.
Wang X, et al. JAMA Netw Open. 2023;doi:10.1001/jamanetworkopen.2023.11966.
108 episode
Bagikan
